Highland Capital Management Fund Advisors, L.P. Abb Vie Inc. Transaction History

Highland Capital Management Fund Advisors, L.P.

$846 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $752,010 - $951,510	-7,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $851,200 - $966,240	-8,000 Reduced 53.33%	7,000 $755,000
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $526,050 - $586,050	5,000 Added 50.0%	15,000 $1.69 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $409,200 - $450,480	-4,000 Reduced 28.57%	10,000 $1.08 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $321,960 - $434,680	-4,000 Reduced 22.22%	14,000 $1.5 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $343,640 - $403,320	4,000 Added 28.57%	18,000 $1.58 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $293,480 - $392,720	4,000 Added 40.0%	14,000 $1.38 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $322,500 - $488,950	-5,000 Reduced 33.33%	10,000 $762,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $944,700 - $1.14 Million	15,000 New	15,000 $1.14 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.

Account